Published in Dev Pharmacol Ther on January 01, 1982
Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature (1997) 14.91
Focal contacts as mechanosensors: externally applied local mechanical force induces growth of focal contacts by an mDia1-dependent and ROCK-independent mechanism. J Cell Biol (2001) 9.73
Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science (1999) 7.12
Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. Nat Cell Biol (1999) 5.84
p140mDia, a mammalian homolog of Drosophila diaphanous, is a target protein for Rho small GTPase and is a ligand for profilin. EMBO J (1997) 5.03
An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med (1999) 3.76
Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination. Virology (1971) 3.57
Role of citron kinase as a target of the small GTPase Rho in cytokinesis. Nature (1998) 3.55
ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett (1996) 3.46
Protein kinase N (PKN) and PKN-related protein rhophilin as targets of small GTPase Rho. Science (1996) 2.99
Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop. J Biol Chem (2000) 2.99
Rhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the rho-binding domain. J Biol Chem (1996) 2.92
Molecular dissection of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma N1E-115 cells. J Cell Biol (1998) 2.81
A novel partner for the GTP-bound forms of rho and rac. FEBS Lett (1995) 2.52
Structural and mechanistic insights into the interaction between Rho and mammalian Dia. Nature (2005) 2.52
Transformation mediated by RhoA requires activity of ROCK kinases. Curr Biol (1999) 2.39
Use and properties of ROCK-specific inhibitor Y-27632. Methods Enzymol (2000) 2.19
Rho effectors and reorganization of actin cytoskeleton. FEBS Lett (1997) 2.19
Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics. Clin Pharmacol Ther (1992) 2.18
Rho-kinase/ROCK is involved in cytokinesis through the phosphorylation of myosin light chain and not ezrin/radixin/moesin proteins at the cleavage furrow. Oncogene (2000) 2.08
Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis. Virology (1971) 2.06
Walking speed as a good predictor for the onset of functional dependence in a Japanese rural community population. Age Ageing (2000) 1.99
Studies of prevalence of Japanese cedar pollinosis among the residents in a densely cultivated area. Ann Allergy (1987) 1.92
Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations. Pharmacogenetics (1997) 1.92
Nomenclature for human CYP2D6 alleles. Pharmacogenetics (1996) 1.91
Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH. Aliment Pharmacol Ther (2001) 1.77
A critical role for a Rho-associated kinase, p160ROCK, in determining axon outgrowth in mammalian CNS neurons. Neuron (2000) 1.76
OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. J Pharmacol Exp Ther (1998) 1.74
N-terminal amino acid sequences of vaccinia virus structural proteins. Virology (1994) 1.71
Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet (1999) 1.61
Hemadsorption and fusion inhibition activities of hemagglutinin analyzed by vaccinia virus mutants. Virology (1990) 1.58
Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19. Leukemia (2006) 1.56
Identification of the Rho-binding domain of p160ROCK, a Rho-associated coiled-coil containing protein kinase. J Biol Chem (1996) 1.55
Melanotic neuroectodermal tumor of infancy in the skull associated with high serum levels of catecholamine. Case report. J Neurosurg (1994) 1.52
Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer. Ann Intern Med (1998) 1.51
Rho-dependent transfer of Citron-kinase to the cleavage furrow of dividing cells. J Cell Sci (2001) 1.50
Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese. Clin Pharmacol Ther (1989) 1.48
Endoscopic MRI: preliminary results of a new technique for visualization and staging of gastrointestinal tumors. Endoscopy (1995) 1.47
Lipoprotein metabolism in Japanese centenarians: effects of apolipoprotein E polymorphism and nutritional status. J Am Geriatr Soc (2001) 1.46
Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Clin Pharmacol Ther (2001) 1.45
Genetic analysis of CYP2C9 polymorphism in a Japanese population. Pharmacogenetics (1997) 1.45
p160ROCK mediates RhoA activation of Na-H exchange. EMBO J (1998) 1.45
Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor. J Gastroenterol (2000) 1.45
Genotyping of S-mephenytoin 4'-hydroxylation in an extended Japanese population. Clin Pharmacol Ther (1996) 1.44
Leukemic cells with 11q23 translocations express granulocyte colony-stimulating factor (G-CSF) receptor and their proliferation is stimulated with G-CSF. Leukemia (1998) 1.44
Allergenic identity between the common floor mite (Dermatophagoides farinae Hughes, 1961) and house dust as a causative antigen in bronchial asthma. J Allergy (1968) 1.43
CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans. Clin Pharmacol Ther (1999) 1.43
Regulation of cell growth-dependent expression of mammalian CDC6 gene by the cell cycle transcription factor E2F. Oncogene (1998) 1.42
Identification of three human type-II classic cadherins and frequent heterophilic interactions between different subclasses of type-II classic cadherins. Biochem J (2000) 1.41
Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors. Jpn J Pharmacol (1999) 1.41
First sporadic cases of non-pneumonic legionellosis, Pontiac fever in Japan. Intern Med (1998) 1.40
Suppression of tumor growth in experimental 9L gliosarcoma model by copper depletion. Neurol Med Chir (Tokyo) (1995) 1.40
Acute myeloid leukaemia with t(9;11)(p22;q23) in a patient treated for adult T cell leukaemia. Br J Haematol (1994) 1.40
A new dural elevator for use during removal of the sphenoid wing. Technical note. J Neurosurg (1988) 1.38
Location of DNA-binding proteins and disulfide-linked proteins in vaccinia virus structural elements. J Virol (1984) 1.38
Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol (1996) 1.38
Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents. Nature (1994) 1.37
Human buprenorphine N-dealkylation is catalyzed by cytochrome P450 3A4. Drug Metab Dispos (1998) 1.35
Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori. Clin Pharmacol Ther (2007) 1.35
KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues. Mol Pharmacol (1995) 1.34
Localization of a mammalian homolog of diaphanous, mDia1, to the mitotic spindle in HeLa cells. J Cell Sci (2001) 1.33
Dose-dependent pharmacokinetics of benzoic acid following oral administration of sodium benzoate to humans. Eur J Clin Pharmacol (1991) 1.32
Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance. Pharmacogenetics (2000) 1.30
An operon containing the genes for cholesterol oxidase and a cytochrome P-450-like protein from a Streptomyces sp. J Bacteriol (1990) 1.26
Characterization of vaccinia polypeptides. Virology (1981) 1.26
31P-nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with chronic lung disease and congestive heart failure. Eur Respir J (1992) 1.26
The disposition of oral amodiaquine in Papua New Guinean children with falciparum malaria. Br J Clin Pharmacol (2005) 1.25
Cloning, functional expression and tissue distribution of human cDNA for the alpha 1C-adrenergic receptor. Biochem Biophys Res Commun (1993) 1.25
Selective binding of sucralfate to gastric ulcer in man. Dig Dis Sci (1981) 1.24
MCM3AP, a novel acetyltransferase that acetylates replication protein MCM3. EMBO Rep (2001) 1.23
Mucin-producing tumor of the pancreas. Cancer (1991) 1.23
Growth ability of human immunodeficiency virus type 1 auxiliary gene mutants in primary blood macrophage cultures. J Gen Virol (1994) 1.22
Adsorption and penetration of the trypsinized vaccinia virion. Virology (1980) 1.22
Double-blind studies of tolerance to praziquantel in Japanese patients with Schistosoma japonicum infections. Bull World Health Organ (1979) 1.21
Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin. Pharmacogenetics (2001) 1.21
Clinicopathologic features of small pancreatic adenocarcinoma. A collective study. Cancer (1996) 1.21
Different regions of Rho determine Rho-selective binding of different classes of Rho target molecules. J Biol Chem (1998) 1.21
Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration. Eur J Clin Pharmacol (1980) 1.21
Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans. Clin Pharmacol Ther (1999) 1.20
Ropporin, a sperm-specific binding protein of rhophilin, that is localized in the fibrous sheath of sperm flagella. J Cell Sci (2000) 1.19
Pharmacokinetics of haloperidol: an update. Clin Pharmacokinet (1999) 1.19
Dissolution of cholesterol gallstones by ursodeoxycholic acid. Lancet (1977) 1.17
Threshold values of visceral fat measures and their anthropometric alternatives for metabolic derangement in Japanese obese boys. Int J Obes Relat Metab Disord (2002) 1.17
Cross-antigenicity among six species of dust mites and house dust antigens. J Allergy (1969) 1.16
Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation. J Pharmacol Exp Ther (1993) 1.16
Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes. Biochem Pharmacol (1993) 1.15
Inhibition of Rho is required for cAMP-induced melanoma cell differentiation. Mol Biol Cell (1998) 1.15
Differential subcellular localization of DNA-dependent protein kinase components Ku and DNA-PKcs during mitosis. J Cell Sci (1999) 1.15
Cloning and expression of a Streptomyces cholesterol oxidase gene in Streptomyces lividans with plasmid pIJ702. Appl Environ Microbiol (1986) 1.14
Value of endoscopic ultrasonography in the detection of anomalous connections of the pancreatobiliary duct. Endoscopy (1991) 1.13
Prolonged hyporesponsiveness of vascular smooth muscle contraction after halothane anesthesia in rabbits. Anesth Analg (1985) 1.13
Citron, a Rho target that affects contractility during cytokinesis. Microsc Res Tech (2000) 1.13
Simultaneous determination of omeprazole and its metabolites in plasma and urine by reversed-phase high-performance liquid chromatography with an alkaline-resistant polymer-coated C18 column. J Chromatogr (1992) 1.13
Comparison of the kinetic disposition and metabolism of E3810, a new proton pump inhibitor, and omeprazole in relation to S-mephenytoin 4'-hydroxylation status. Clin Pharmacol Ther (1995) 1.12
A nonhuman primate model for human cerebral malaria: rhesus monkeys experimentally infected with Plasmodium fragile. Exp Parasitol (1994) 1.11
Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population. J Pharmacol Exp Ther (1992) 1.11
Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation. Oncogene (1999) 1.11
Late bone metastasis from an encapsulated follicular carcinoma of the thyroid without capsular and vascular invasion. Pathol Int (1996) 1.11
High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin's lymphoma. Am J Pediatr Hematol Oncol (1993) 1.10